ICANS
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy (NCT04975555) | University of Alabama at Birmingham | 2021-11-15 |
Track ICANS automatically
Every clearance here is in the API, with alerts when new ones post.